Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin for Prediabetes Remission
NCT06448130Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of henagliflozin in prediabetes, sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT06448130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448130.